Clin2
NCT05737693Possibly a fitActive, not recruiting

Ketamine plus weekly therapy for severe PTSD

Posttraumatic Stress Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests whether adding ketamine to a structured, one-week psychological therapy program can reduce severe PTSD symptoms. It may help people who have had PTSD for a long time and still feel very affected.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
350 people
Ages
21 years to 70 years
Study type
Interventional

Who can take part

  • You’re between 21 and 70 years old.
  • You have chronic (long-lasting) PTSD for more than 1 year, and your PTSD severity is high on the clinician-rated CAPS-5 test.
  • You can take part safely with ketamine—no major medical/neurologic conditions and no medicines that make ketamine unsafe.
  • If you’re on certain psychiatric medicines, your doses must be stable for at least 4 weeks before starting study treatment.
  • You must not have certain mental health conditions (like schizophrenia/psychosis) or recent bipolar mania/hypomania.
  • You must not have recent substance use problems, serious suicide risk, or be pregnant/breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06559826Recruiting· Phase 2
Ketamine therapy with or without talk for depression

This study compares ketamine alone to ketamine combined with psychotherapy for treating depression. It may help if you have moderate to severe depression and want to see if adding talk therapy improves results.

New York, New York
NCT05915013Recruiting· Phase 1
Brain-targeting study of ketamine response in treatment-resistant depression

This early-stage study looks at how parts of brain cells respond to ketamine in people with depression who have not improved with usual antidepressants. It may help researchers find why ketamine works for some people and not others, and who might benefit.

New Haven, Connecticut
NCT06597695Recruiting· Phase 1/Phase 2
Ketamine group therapy for Spanish-speaking adults with depression

This trial tests whether ketamine-assisted group therapy can help Spanish-speaking Latinx adults with major depression. You would receive ketamine in a supportive group setting, with the goal of improving your mood and quality of life.

Chelsea, Massachusetts
NCT07009158Not yet recruiting· Phase 1/Phase 2
Ketamine plus therapy for pain and PTSD

This trial tests if ketamine combined with talk therapy helps people with both chronic pain and PTSD. Participants receive ketamine through an IV in group therapy sessions over several weeks, with the goal of reducing pain and PTSD symptoms.

NCT06228391Not yet recruiting· Phase 2
Ketamine for PTSD and Depression after Brain Injury

This study tests whether ketamine can help Veterans with both PTSD and depression who have also had a traumatic brain injury (TBI). If you have tried antidepressants before without success, this may be a new option to explore.

Minneapolis, Minnesota
NCT07247006Not yet recruiting· Phase 2
Ketamine with therapy for hard-to-treat depression

This trial is testing whether a combination of ketamine and talk therapy can help people with depression that hasn't responded to other treatments. You will receive ketamine in a safe, supervised setting while working with a therapist.

Rochester, New York

Hear when a new Posttraumatic Stress Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.